期刊文献+

腺病毒载体介导的VEGF基因转染对C17.2神经干细胞凋亡的影响 被引量:3

Effect of Recombinant Adenovirus Containing VEGF Gene on Apoptosis of Neural Stem Cells After Hypoxia In Vitro
暂未订购
导出
摘要 【目的】探讨重组腺病毒介导血管内皮生长因子(VEGF)165基因对缺氧状态下对神经干细胞凋亡的作用。【方法】体外培养C17.2神经干细胞,建立神经干细胞缺氧模型;将携带人类VEGF基因的重组腺病毒感染C17.2神经干细胞;Western-blot法检测VEGF蛋白的表达;流式细胞术测定细胞凋亡率;Hoechst33342染色荧光显微镜观察凋亡小体。【结果】转染pAdCMVVEGF165的C17.2神经干细胞成功表达VEGF蛋白;缺氧后神经干细胞凋亡率为(19.98%±0.55%),转染pAdCMVVEGF165后的细胞凋亡率为(10.38%±0.48%,P<0.01),而转染pAdCMVVEGF165+VEGF反义寡核脱氧核酸经干细胞凋亡率为(19.07%±0.64%),与对照组无显著差异(P>0.05)。【结论】腺病毒介导的VEGF165基因能成功表达VEGF;外源性VEGF对C17.2神经干细胞具有抗凋亡作用,能够提高C17.2神经干细胞对缺氧的耐受性,有利于神经干细胞的生存。 Objective] To investigate the effect of vascular endothelial growth factor (VEGF) gene on the apoptosis of neural stem cell after hypoxia in vitro. [Methods] C17.2 neural stem cell was cultured and infected by recombinant adenovirus containing VEGF gene, then cultured under hypoxic condition; VEGF expression was detected by Western blot analysis, the apoptotic ratio was inspected by flow cytometry, and the apoptosis bodies was observed by Hoechst33342 staining under fluorescence microscope. [Results] The expression of VEGF in pAdCMV VEGF165 infected cells was significantly increased. The apoptotic ratio of neural stem cells after hypoxia was (19.98% ± 0.55%). The apoptotic ratio of neural stem cells infected by pAdCMV VEGF165 after hypoxia was (10.38% ± 0.48%, P< 0.01), the apoptotic ratio of neural stem cells infected by pAdCMV VEGF165 and anti-sense oligodeoxynucleotide after hypoxia was (19.07%±0.64%, P< 0.01). [Conclusions] Recombinant adenovirus containing VEGF gene can transfer C17.2 neural stem cell efficiently and the exogenous VEGF expressed highly in vitro. Recombinant adenovirus media VEGF gene transfer could reduce C17.2 neural stem cell apoptosis after hypoxia.
出处 《中山大学学报(医学科学版)》 CAS CSCD 北大核心 2005年第3期293-296,共4页 Journal of Sun Yat-Sen University:Medical Sciences
基金 广东省卫生厅科研基金资助项目(B2004047)
关键词 神经干细胞 血管内皮生长因子 凋亡 腺病毒载体 缺氧 neural stem cell vascular endothelial growth factor apoptosis adenovirus vector hypoxia
  • 相关文献

参考文献9

  • 1Cheng AW,Chan SL,Milhavet O,et al. p38 MAP kinase mediates nitric oxide- induced apoptosis of neural progenitor cell[J]. J Biol Chem, 2001, 276(46):43320-7.
  • 2Yasuhara T, Shingo T, Kobayash K, et al.Neuroprotective effects of vascular endothelial growth factor (VEGF) upon dopaminergic neurons in a rat model of Parkinson's disease [J]. Eur J Neurosci,2004, 19( 6):1494-500.
  • 3Jin KL, Mao XO, Batteur SP, et al. Caspase-3 and the regulation of hypoxic neuronal death by vascular endothehal growth factor[J]. Neurosci, 2001, 108(2):351-8.
  • 4沈庆煜,黎祥喷,陶恩祥,肖颂华,王莉梅,邢诒刚.人血管内皮生长因子165基因腺病毒载体的构建及其在C17.2神经干细胞的表达[J].中山大学学报(医学科学版),2005,26(B03):152-155. 被引量:3
  • 5Snyder EY, Deitcher DL, Walsh C, et al. Multipotent neural cell lines can engraft and participate in development of mouse cerebellum[J]. Cell, 1992, 68 (1):33-51.
  • 6Kondziolka D, Wechsler L, Achim C. Neural Transplantation for stroke[J]. J Clin Neurosci, 2002, 9(3):225-30.
  • 7Sondell M, Lundborg G, Kanje M. Vascular endothelial growth factor has neurotrophic activity and stimulates axonal outgrowth, enchacing cell survival and Schwann cell proliferation in the peripheral nervous system[J]. J Neurosci,1999, 19(14):5731-40.
  • 8Jin KL, Mao XO, Greenberg DA, et al. Vascular endothelial growth factor rescues HN53 neural cells from death induced by serum withdrwlal [J]. J Mol Neurosci, 2000, 14(3):197-203.
  • 9Maurer MH, Tripps WKC, Feldmann RE, et al.Expression of vascular endothelial growth factor and its receptors in rat neural stem cells[J]. Neurosci Lett,2003, 344(3): 165-8.

二级参考文献9

  • 1李庆军,刘军,赵东晖,肖颂华,黎祥喷,沈庆煜,阎俊,邢诒刚.含有NuRR1基因的重组复制缺陷性腺病毒的构建和鉴定[J].中山大学学报(医学科学版),2004,25(B06):76-78. 被引量:4
  • 2Yaneopoulos GD, Davis S, Gale NW, et al. Vascular-specific growth factors and blood vessel formation[J]. Nature, 2000,407 (6801):242-8.
  • 3Koransky ML, Robbins RC, Blau HB. VEGF gene delivery for treatment of ischemic cardiovascular disease[J]. Trends Cardiovasc Med, 2002, 12(3): 108-14.
  • 4Jin K, Zhu Y, Sun Y, et al. Vascular endothelial growth factor (VEGF) stimulates neurogenesis in vitro and in vivo[J]. Proc Natl Acad Sci U S A,2002,99(18):11946-50.
  • 5Fukunaga A, Uchida K, Hara K, et al. Differentiation and angiogenesis of central nervous system stem cells implanted with mesenchyme into ischemic rat brain[J]. Cell Transplant. 1999, 8(4):435-41.
  • 6Snyder EY. Neural stem-like cells: developmental lessons with therapeutic potential[J]. Neuroseientist, 1998, 4(8): 408- 25.
  • 7Synder EY, Deitcher DL, Walsh C, et al. Multipotent neural cell lines can engraft and participate in development of mouse cerebellum[J]. Cell, 1992, 68(1):33-51.
  • 8Ku DD, Zaleski JK, Liu S, et al. Vascular endothelial growth factor induces EDRF-dependent relaxation in coronary arteries [J]. Am J Physiol, 1993, 265(2Pt2):H586-92.
  • 9李子俊,胡品津,余细勇.人血管内皮生长因子的克隆表达及活性鉴定[J].中山医科大学学报,2001,22(3):177-179. 被引量:4

共引文献2

同被引文献26

  • 1黎祥喷,沈庆煜,王艺东,叶剑虹,邢诒刚.NURR1基因修饰C17.2神经干细胞移植治疗脑梗死[J].中国组织工程研究与临床康复,2007,11(24):4760-4763. 被引量:3
  • 2Clements JA, Willemsen NM, Myers SA, et al. The tissue kallikrein family of serine proteases: functional roles in human disease and potential as clinical biomarkers[J]. Crit Rev Clin Lab Sci, 2004, 41 (3): 265-312.
  • 3Magklara A, Mellati AA, Wasney GA, et al. Characterization of the enzymatic activity of human kallikrein 6: autoactivation, substrate specificity, and regulation by inhibitors[J]. Biochem Biophys Res Commun, 2003, 307(4): 948-955.
  • 4Chao J, Chao L. Experimental therapy with tissue kallikrein against cerebral ischemia[J]. Front Biosci, 2006, 11: 1323-1327.
  • 5Longa EZ, Weinstein PR, Carlson S, et al. Reversible middle cerebral artery occlusion without craniectomy in rats [J]. Stroke, 1989, 20(1): 84-91.
  • 6Chen J, Li Y, Wang L, et al. The therapy benefit of intravenous administration of bone marrow stromal cells after cerebral isehemia in rats [J]. Stroke, 2001, 32(4): 1005-1011.
  • 7Chun FX, Hang Y, Cesar V, et al. Kallikrein gene transfer protects against ischemia stroke by promoting glial cell migration and inhibiting apoptosis [J]. Hypertension, 2004, 43(2): 452-459.
  • 8Costanza E, Maria BS. Rescue of imparied angiogenesis in spontaneously hypertensive rats by intramuscular human tissue kallikrein gene transfer[J]. Hypertension, 2001, 38(5): 136-141.
  • 9Emanueli C, Zacheo A, Minasi A, et al human tissue Kallikrein gene delivery induces angiogenesis in normoperfused skeletal muscle[J]. Arterioscler Thromb Vasc Biol, 2000, 20(11): 2379-2385.
  • 10Colman RW. Inhibitiong of angiogenesis by a monoclonal antibody t o kininogen as well as by kininostatin which block proangiogenic high molecular weight kininogen [J]. Int Immunopharmacol, 2002, 2(1): 1887-1894.

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部